shortagewatch

Home / Pantoprazole / Germany

DE ATC A02BC02 · updated 2 Nov 2026

Pantoprazole shortage in Germany

Is there a Pantoprazole shortage in Germany?

Yes. As of 2 Nov 2026, 15 Pantoprazole products are reported short in Germany, the first since 1 Feb 2026. The company estimate for the return is 13 Nov 2026 (latest 30 Nov 2026). Main reason: manufacturing problem.

Also short in Canada, Italy, Austria, Belgium, Czechia, Norway, Sweden, Australia. All countries.

Affected products in Germany

CountryProductCompanySinceExpected backReason
DEPANTOPRAZOL BASICS 40 mg magensaftresistente TablettenBasics GmbH1 Feb 202630 Nov 2026Active ingredient shortage
Probleme beim Wirkstoffhersteller
DEPANTOPRAZOL BASICS 40 mg magensaftresistente TablettenBasics GmbH1 Feb 202630 Nov 2026Active ingredient shortage
Probleme beim Wirkstoffhersteller
DEPANTOPRAZOL BASICS 40 mg magensaftresistente TablettenBasics GmbH1 Feb 202630 Nov 2026Active ingredient shortage
Probleme beim Wirkstoffhersteller
DEPANTOPRAZOL BASICS 40 mg magensaftresistente TablettenBasics GmbH1 Feb 202630 Nov 2026Active ingredient shortage
Probleme beim Wirkstoffhersteller
DEPantoprazol Denk 40 mg magensaftresistente TablettenDenk Pharma GmbH & Co. KG17 Feb 202630 Nov 2026Manufacturing problem
Produktionsproblem
DEPantoprazol Denk 40 mg magensaftresistente TablettenDenk Pharma GmbH & Co. KG17 Feb 202630 Nov 2026Manufacturing problem
Produktionsproblem
DEPantoprazol Denk 40 mg magensaftresistente TablettenDenk Pharma GmbH & Co. KG17 Feb 202630 Nov 2026Manufacturing problem
Produktionsproblem
DEPANTOPRAZOL BASICS 20 mg magensaftresistente TablettenBasics GmbH2 Apr 202630 Nov 2026Manufacturing problem
Produktionsproblem
DEPANTOPRAZOL BASICS 20 mg magensaftresistente TablettenBasics GmbH2 Apr 202630 Nov 2026Manufacturing problem
Produktionsproblem
DEPANTOPRAZOL BASICS 20 mg magensaftresistente TablettenBasics GmbH2 Apr 202630 Nov 2026Manufacturing problem
Produktionsproblem
DEPANTOPRAZOL BASICS 20 mg magensaftresistente TablettenBasics GmbH2 Apr 202630 Nov 2026Manufacturing problem
Produktionsproblem
DEPantoprazol-Micro Labs 40 mg magensaftresistente TablettenMicro Labs GmbH3 Jul 202613 Nov 2026Increased demand
Erhöhte Nachfrage
DEPantoprazol-Micro Labs 40 mg magensaftresistente TablettenMicro Labs GmbH3 Jul 202613 Nov 2026Increased demand
Erhöhte Nachfrage
DEPantoprazol-Micro Labs 40 mg magensaftresistente TablettenMicro Labs GmbH3 Jul 202613 Nov 2026Increased demand
Erhöhte Nachfrage
DEPantoprazol-Micro Labs 20 mg magensaftresistente TablettenMicro Labs GmbH3 Sep 202626 Nov 2026Increased demand
Erhöhte Nachfrage

Source

BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.